AxoGen (AXGN) Initiates BLA Submission for Avance Nerve Graft
https://www.zacks.com/stock/news/2275648/axogen-axgn-initiates-bla-submission-for-avance-nerve-graft?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2275648
May 17, 2024 - AxoGen (AXGN) starts the process of BLA submission to the FDA for the approval of its Avance Nerve Graft.
0
Pages: 1
Page 1